Dr. Rhonda Patrick on health: what the evidence says · JRE #773
SUBJECT: HEALTH
Not a true/false call. Every claim is logged with its sources; read the exhibits below.
So it makes sense that nature would make a way that showed that people that take preformed ALA, alpha-linolenic acid, have to take 33.5 times more than preformed DHA or EPA to get the same amount of DHA and EPA in the brain.
What the evidence says 01 / RECORD
Patrick claimed that ALA, the plant-derived omega-3 fatty acid, must be consumed at roughly 33.5 times the dose of preformed DHA/EPA to raise brain DHA/EPA to the same level. Peer-reviewed research confirms that human conversion of dietary ALA to long-chain omega-3s is very inefficient: a widely cited review (Gerster 1998) reports conversion to long-chain metabolites at approximately 6% for EPA and 3.8% for DHA on a typical high-saturated-fat background diet, and notes that a diet high in n-6 PUFA reduces conversion by a further 40-50%. A 3.8% ALA-to-DHA conversion rate implies roughly 26-fold more ALA is needed to match a given amount of preformed DHA, in the same order of magnitude as the 33.5x figure cited. A more recent review (2022) confirms that dietary ALA intake reliably raises circulating/tissue ALA and, to a lesser extent, EPA, but generally has little to no effect on DHA levels, supporting the broader point that preformed DHA/EPA intake is needed to reliably raise brain omega-3 status. However, neither source, nor any other identified in this review, independently corroborates the specific 33.5-fold figure; conversion-efficiency estimates vary across studies by diet composition, sex, and genetics, so published ratios cluster in a range rather than at one precise number. Status: the direction and rough order of magnitude of the claim (ALA requires a much larger, roughly 25-to-50-fold, dose than preformed DHA/EPA for equivalent brain levels) is well-supported, but the specific '33.5 times' figure could not be independently verified against a single consistent published source.